TopNews United Kingdom (blog)

<img alt="" height="1" width="1" />
FDA Advisory Panel to Discuss MS Drug
MedPage Today
SILVER SPRING, Md. -- Fingolimod (Gilenia), the first oral drug aimed at treating the relapsing-remitting form of multiple sclerosis, will be the subject of an FDA advisory committee hearing here tomorrow. ...
FDA staff eyes safety of Novartis&#39; MS drugReuters
FDA: MS Drug Effective, But Has &#39;Safety Issues&#39;Wall Street Journal
Health Highlights: June 8, 2010BusinessWeek
The Associated Press -The Market Financial -Benzinga
all 202 news articles &raquo;